Phase 4 study of dexmedetomidine for postoperative sedation in patients undergoing repair of thoracoabdominal aortic aneurysms.
Phase of Trial: Phase IV
Latest Information Update: 06 Apr 2017
At a glance
- Drugs Dexmedetomidine (Primary)
- Indications Postoperative pain; Sedation
- Focus Therapeutic Use
- 22 Sep 2009 Status changed from not yet recruiting to discontinued as reported by ClinicalTrials.gov.
- 22 Sep 2009 Additional lead trial centre (Hospira, Inc.) identified as reported by ClinicalTrials.gov.
- 28 Dec 2006 New trial record.